BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 45 found
  Current Search:  toprol: 45     

HTML
100%
FDA warns Sandoz on unvalidated manufacturing
The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina.

In its letter to Sandoz CEO...

Outsourcing Pharma:  Aug 29 2008 1:28PM
Matching: toprol
Find similar documents
HTML
100%
FDA warns Sandoz on unvalidated manufacturing
The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina.

In its letter to Sandoz CEO...

In-Pharmatechnologist:  Aug 28 2008 2:51PM
Matching: toprol
Find similar documents
HTML
100%
U.S. warns Novartis generic unit on plant problems
WASHINGTON U.S.

regulators have warned Novartis AG's generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released Tuesday said.

Food and Drug Administration inspectors found the company failed to...

SignOn San Diego:  Aug 27 2008 10:46PM
Matching: toprol
Find similar documents
HTML
100%
US warns Novartis generic unit on plant problems
WASHINGTON, Aug 26 (Reuters) - U.S.

regulators have warned Novartis AG's <NOVN.VX> generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released on Tuesday said.

Food and Drug Administration...

Interactive Investor International:  Aug 26 2008 3:14PM
Matching: toprol
Find similar documents
HTML
100%
US warns Novartis generic unit on plant problems
WASHINGTON, Aug 26 (Reuters) - U.S.

regulators have warned Novartis AG's generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released on Tuesday said.

Food and Drug Administration inspectors found...

Sharewatch:  Aug 26 2008 2:48PM
Matching: toprol
Find similar documents
HTML
100%
FDA warns Novartis generic drug unit Sandoz
WASHINGTON -- US regulators have warned Novartis AG's generic drug unit Sandoz about manufacturing problems at a North Carolina plant, according to a letter.

Food and Drug Administration inspectors found the company failed to properly...

Business Spectator:  Aug 26 2008 6:16PM
Matching: toprol
Find similar documents
HTML
100%
UPDATE 1-US warns Novartis generic unit on plant problems
WASHINGTON, Aug 26 (Reuters) - U.S.

regulators have warned Novartis AG's generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released on Tuesday said.

Food and Drug Administration inspectors found...

Forbes.com:  Aug 26 2008 5:19PM
Matching: toprol
Find similar documents
HTML
100%
Novartis Unit Sandoz Gets FDA Warning On Drug Production
ZURICH -(Dow Jones)- Novartis AG's (NVS) generics unit Sandoz has received a warning letter from the U.S.

Food and Drug Administration, saying an inspection has revealed significant deviations from manufacturing regulations.

The letter,...

Morningstar.com:  Aug 26 2008 5:04PM
Matching: toprol
Find similar documents
HTML
100%
UPDATE: FDA Warns Novartis Unit Sandoz On Drug Production
(Adds company comment.) ZURICH -(Dow Jones)- Novartis AG's (NVS) generics unit Sandoz has received a warning letter from the U.S.

Food and Drug Administration, saying an inspection has revealed significant deviations from manufacturing...

Morningstar.com:  Aug 26 2008 5:02PM
Matching: toprol
Find similar documents
HTML
100%
UPDATE 1-US warns Novartis generic unit on plant problems
WASHINGTON, Aug 26 (Reuters) - U.S.

regulators have warned Novartis AG's <NOVN.VX> generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released on Tuesday said.

Food and Drug Administration...

Interactive Investor International:  Aug 26 2008 4:28PM
Matching: toprol
Find similar documents
HTML
100%
UPDATE 1-US warns Novartis generic unit on plant problems
WASHINGTON, Aug 26 (Reuters) - U.S.

regulators have warned Novartis AG's generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released on Tuesday said.

Food and Drug Administration inspectors found...

Sharewatch:  Aug 26 2008 3:43PM
Matching: toprol
Find similar documents
HTML
100%
US warns Novartis generic unit on plant problems
(Adds Novartis comment, details from letter, shares) WASHINGTON (Reuters) - U.S.

regulators have warned Novartis (nyse: NVS - news - people ) AG's generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter...

Forbes.com:  Aug 26 2008 3:10PM
Matching: toprol
Find similar documents
HTML
100%
Novartis Unit Sandoz Gets FDA Warning On Drug Production (DJ)
says these deviations occurred in the manufacturing of Metoprolol Succinate ER tablets, a generic version of AstraZeneca PLC's (AZN) Toprol XL.

The warning letter is dated Aug.

After an inspection of Sandoz's manufacturing...

Easy Bourse:  Aug 26 2008 3:03PM
Matching: toprol
Find similar documents
HTML
100%
Novartis Unit Sandoz Gets FDA Warning On Drug Production
ZURICH -(Dow Jones)- Novartis AG's (NVS) generics unit Sandoz has received a warning letter from the U.S.

Food and Drug Administration, saying an inspection has revealed significant deviations from manufacturing regulations.

The letter,...

Lloyd's:  Aug 26 2008 3:01PM
Matching: toprol
Find similar documents
HTML
100%
UPDATE 1-US warns Novartis generic unit on plant problems
(Adds Novartis comment, details from letter, shares) WASHINGTON, Aug 26 (Reuters) - U.S.

regulators have warned Novartis AG's (NOVN.VX: Quote, Profile, Research, Stock Buzz) generic drug unit Sandoz about manufacturing problems at a North...

Reuters:  Aug 26 2008 2:43PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma says fiscal Q1 profit doubled, but sales miss Wall Street estimates
LOUIS (AP) - KV Pharmaceutical Co.

said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.

For the three months ended June 30, KV reported a profit of $12.5...

Canadian Business Magazine:  Aug 12 2008 10:05PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma 1Q profit doubles, but sales disappoint
KV Pharmaceutical Co.

said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.

For the three months ended June 30, KV reported a profit of $12.5 million, or 23...

Forbes.com:  Aug 12 2008 5:22PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma 1Q profit doubles, but sales disappoint
For the three months ended June 30, KV reported a profit of $12.5 million, or 23 cents per Class A share.

A year ago, it earned $6.2 million, or 12 cents per share.

Revenue jumped 30 percent to $148.9 million from $114.4 million, aided...

Yahoo! Canada:  Aug 12 2008 5:20PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma says fiscal 1st - quarter profit doubled, but sales miss Wall Street estimates
LOUIS (AP) - KV Pharmaceutical Co.

said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.

For the three months ended June 30, KV reported a profit of $12.5...

Canadian Business Magazine:  Aug 12 2008 5:20PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma 1Q profit doubles, but sales disappoint
LOUIS (AP) - KV Pharmaceutical Co.

said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.

For the three months ended June 30, KV reported a profit of $12.5...

AP via MSN Money:  Aug 12 2008 5:18PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma says fiscal 1st-quarter profit doubled, but sales miss Wall Street estimates
LOUIS (AP) - KV Pharmaceutical Co.

said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.

For the three months ended June 30, KV reported a profit of $12.5...

Canadian Business Magazine:  Aug 12 2008 5:12PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma 1Q profit doubles, but sales disappoint
LOUIS (AP) -- KV Pharmaceutical Co.

said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.For the three months ended June 30, KV reported a profit of $12.5...

AP via Yahoo!:  Aug 12 2008 5:12PM
Matching: toprol
Find similar documents
HTML
100%
KV Pharma 1Q profit doubles, but sales disappoint
LOUIS - KV Pharmaceutical Co.

said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.

For the three months ended June 30, KV reported a profit of $12.5 million,...

CNBC:  Aug 12 2008 5:09PM
Matching: toprol
Find similar documents
HTML
100%
POISE Data Complicate Peri-op ?-Blocker Therapy
Risk for stroke, death outweighs benefits Adam Marcus Perioperative administration of ?-blockers has been enshrined in society guidelines for more than a decade.

But recently published data showing that the drugs cause more harm than good...

Pharmacy Practice News:  Aug 6 2008 4:25PM
Matching: toprol
Find similar documents
HTML
100%
Metoprolol
Brand Name(s): Lopressor,Toprol-XL Generic Name is metoprolol tartrate (ma TOE proe lol / TAR trayt) and Brand Name is Lopressor (loe PRES sor) Generic Name for extended release is metoprolol succinate (ma TOE proe lol / SUK sin ate) and...
Peoples Pharmacy:  Aug 3 2008 4:31PM
Matching: toprol
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.